The Travelers Companies (TRV)
(Delayed Data from NYSE)
$236.05 USD
-0.27 (-0.11%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $236.00 -0.05 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$236.05 USD
-0.27 (-0.11%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $236.00 -0.05 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Zacks News
The Travelers Companies Inc., a holding company, is principally engaged, through its subsidiaries, in providing a wide variety of property and casualty insurance and surety products and services to businesses, organizations and individuals in the United States. and select international markets. Travelers operates its business through three segments: The Business Insurance segment, The Personal Insurance segment, and The Bond & Specialty Insurance segment.
Marsh & McLennan (MMC) Q4 Earnings Beat on Solid US Business
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results benefit from expanding operations across Latin America and EMEA, partly offset by higher operating expenses.
RLI's Q4 Earnings Top Estimates on Strong Premium Growth
by Zacks Equity Research
RLI's fourth quarter earnings reflect continued premium growth across all product segments.
5 Blue-Chip Stocks to Buy as Dow Hits a New Milestone
by Nalak Das
We have narrowed our search to five Dow stocks that have strong earnings growth potential for 2024. These are: AXP, AAPL, MSFT, IBM, TRV.
W.R. Berkley's (WRB) Q4 Earnings Beat on Higher Premiums
by Zacks Equity Research
W.R. Berkley's (WRB) Q4 results reflect higher premiums, a rise in the core portfolio, increased underwriting income and an improvement in the loss ratio.
Progressive's (PGR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Progressive's (PGR) fourth-quarter 2023 results reflect year-over-year improvement in the top line.
AXIS Capital (AXS) Provides Preliminary 2023 Financial Results
by Zacks Equity Research
AXIS Capital (AXS) anticipates net income available to shareholders of $346 million, operating income of $486 million and book value per share of $54.06 for the year ended Dec 31, 2023.
CNA Financial (CNA) Gains 13.4% in 6 Months: More Room to Run?
by Zacks Equity Research
CNA Financial (CNA) stock soars on the back of new businesses, improved non-catastrophe current accident year underwriting results and effective capital deployment.
2 Financial Stocks to Buy After Massive Earnings Beats
by Shaun Pruitt
After blowing away their quarterly earnings expectations last Friday, The Travelers Companies (TRV) and World Acceptance (WRLD) are two top-rated Zacks stocks that investors will want to consider.
Brown & Brown's (BRO) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Brown & Brown's (BRO) Q4 results reflect strong organic growth, improved EBITDAC margin and higher net investment income, as well as lower expenses.
Are Investors Undervaluing The Travelers Companies (TRV) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Company News for Jan 22, 2024
by Zacks Equity Research
Companies in The News Are: AAPL, TRV, OZK, PEP
Travelers (TRV) Q4 Earnings Beat Estimates on Lower Cat Loss
by Zacks Equity Research
Travelers (TRV) incurs lower catastrophe losses in the fourth quarter of 2023. The company reports record premiums, reflecting strong growth across all three segments.
Market Awaits Consumer Sentiment Data
by Zacks Equity Research
Market Awaits Consumer Sentiment Data
Pre-Markets Continue Bouncing Back; TRV +5% on Q4 News
by Mark Vickery
We've actually been on a relative plateau at current high levels since mid-December.
Here's What Key Metrics Tell Us About Travelers (TRV) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Travelers (TRV) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Travelers (TRV) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Travelers (TRV) delivered earnings and revenue surprises of 39.09% and 0.24%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Markets Rebound on Economic Prints, Fed Speak
by Mark Vickery
Tomorrow, we'll finish a content-heavy week with more economic grist for the mill.
4 P&C Insurance Stocks With Decent Dividend Yield to Bank on
by Sushmita Sarker
Here we pick four insurance stocks, CNA Financial (CNA), American Financial (AFG), Travelers Companies (TRV) and Axis Capital (AXS), which have a solid five-year dividend growth history.
The Zacks Analyst Blog Highlights Apple, Boeing, Coca-Cola, Procter & Gamble and Travelers
by Zacks Equity Research
Apple, Boeing, Coca-Cola, Procter & Gamble and Travelers are included in this Analyst Blog.
Progressive (PGR) to Report Q4 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Progressive (PGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy CNA Financial (CNA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Arthur J. Gallagher (AJG) Buys MGB, Boosts Medical Reinsurance
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of MGB is set to enhance the growth of its medical reinsurance business and expand service offerings.
5 Blue-Chip Stocks to Buy Ahead of Earnings Results
by Nalak Das
We have narrowed our search to five Dow stocks that are poised to beat on earnings results. These are: AAPL, KO, BA, PG, TRV.
Why The Travelers (TRV) Might Surprise This Earnings Season
by Zacks Equity Research
The Travelers (TRV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for Travelers (TRV) This Earnings Season?
by Zacks Equity Research
Improved pricing, solid renewal rate change, strong retention and exposure growth are likely to aid Travelers Companies' (TRV) fourth-quarter results.